Cargando…

The use of artificial intelligence models to predict survival in patients with laryngeal squamous cell carcinoma

Most recent survival prediction has been based on TNM staging, which does not provide individualized information. However, clinical factors including performance status, age, sex, and smoking might influence survival. Therefore, we used artificial intelligence (AI) to analyze various clinical factor...

Descripción completa

Detalles Bibliográficos
Autores principales: Choi, Nayeon, Kim, Junghyun, Yi, Heejun, Kim, HeeJung, Kim, Tae Hwan, Chung, Myung Jin, Ji, Migyeong, Kim, Zero, Son, Young-Ik
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272182/
https://www.ncbi.nlm.nih.gov/pubmed/37322055
http://dx.doi.org/10.1038/s41598-023-35627-1
_version_ 1785059436975357952
author Choi, Nayeon
Kim, Junghyun
Yi, Heejun
Kim, HeeJung
Kim, Tae Hwan
Chung, Myung Jin
Ji, Migyeong
Kim, Zero
Son, Young-Ik
author_facet Choi, Nayeon
Kim, Junghyun
Yi, Heejun
Kim, HeeJung
Kim, Tae Hwan
Chung, Myung Jin
Ji, Migyeong
Kim, Zero
Son, Young-Ik
author_sort Choi, Nayeon
collection PubMed
description Most recent survival prediction has been based on TNM staging, which does not provide individualized information. However, clinical factors including performance status, age, sex, and smoking might influence survival. Therefore, we used artificial intelligence (AI) to analyze various clinical factors to precisely predict the survival of patients with larynx squamous cell carcinoma (LSCC). We included patients with LSCC (N = 1026) who received definitive treatment from 2002 to 2020. Age, sex, smoking, alcohol consumption, Eastern Cooperative Oncology Group (ECOG) performance status, location of tumor, TNM stage, and treatment methods were analyzed using deep neural network (DNN) with multi-classification and regression, random survival forest (RSF), and Cox proportional hazards (COX-PH) model for prediction of overall survival. Each model was confirmed with five-fold cross validation, and performance was evaluated using linear slope, y-intercept, and C-index. The DNN with multi-classification model demonstrated the highest prediction power (1.000 ± 0.047, 0.126 ± 0.762, and 0.859 ± 0.018 for slope, y-intercept, and C-index, respectively), and the prediction survival curve showed the strongest agreement with the validation survival curve, followed by DNN with regression (0.731 ± 0.048, 9.659 ± 0.964, and 0.893 ± 0.017, respectively). The DNN model produced with only T/N staging showed the poorest survival prediction. When predicting the survival of LSCC patients, various clinical factors should be considered. In the present study, DNN with multi-class was shown to be an appropriate method for survival prediction. AI analysis may predict survival more accurately and improve oncologic outcomes.
format Online
Article
Text
id pubmed-10272182
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-102721822023-06-17 The use of artificial intelligence models to predict survival in patients with laryngeal squamous cell carcinoma Choi, Nayeon Kim, Junghyun Yi, Heejun Kim, HeeJung Kim, Tae Hwan Chung, Myung Jin Ji, Migyeong Kim, Zero Son, Young-Ik Sci Rep Article Most recent survival prediction has been based on TNM staging, which does not provide individualized information. However, clinical factors including performance status, age, sex, and smoking might influence survival. Therefore, we used artificial intelligence (AI) to analyze various clinical factors to precisely predict the survival of patients with larynx squamous cell carcinoma (LSCC). We included patients with LSCC (N = 1026) who received definitive treatment from 2002 to 2020. Age, sex, smoking, alcohol consumption, Eastern Cooperative Oncology Group (ECOG) performance status, location of tumor, TNM stage, and treatment methods were analyzed using deep neural network (DNN) with multi-classification and regression, random survival forest (RSF), and Cox proportional hazards (COX-PH) model for prediction of overall survival. Each model was confirmed with five-fold cross validation, and performance was evaluated using linear slope, y-intercept, and C-index. The DNN with multi-classification model demonstrated the highest prediction power (1.000 ± 0.047, 0.126 ± 0.762, and 0.859 ± 0.018 for slope, y-intercept, and C-index, respectively), and the prediction survival curve showed the strongest agreement with the validation survival curve, followed by DNN with regression (0.731 ± 0.048, 9.659 ± 0.964, and 0.893 ± 0.017, respectively). The DNN model produced with only T/N staging showed the poorest survival prediction. When predicting the survival of LSCC patients, various clinical factors should be considered. In the present study, DNN with multi-class was shown to be an appropriate method for survival prediction. AI analysis may predict survival more accurately and improve oncologic outcomes. Nature Publishing Group UK 2023-06-15 /pmc/articles/PMC10272182/ /pubmed/37322055 http://dx.doi.org/10.1038/s41598-023-35627-1 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Choi, Nayeon
Kim, Junghyun
Yi, Heejun
Kim, HeeJung
Kim, Tae Hwan
Chung, Myung Jin
Ji, Migyeong
Kim, Zero
Son, Young-Ik
The use of artificial intelligence models to predict survival in patients with laryngeal squamous cell carcinoma
title The use of artificial intelligence models to predict survival in patients with laryngeal squamous cell carcinoma
title_full The use of artificial intelligence models to predict survival in patients with laryngeal squamous cell carcinoma
title_fullStr The use of artificial intelligence models to predict survival in patients with laryngeal squamous cell carcinoma
title_full_unstemmed The use of artificial intelligence models to predict survival in patients with laryngeal squamous cell carcinoma
title_short The use of artificial intelligence models to predict survival in patients with laryngeal squamous cell carcinoma
title_sort use of artificial intelligence models to predict survival in patients with laryngeal squamous cell carcinoma
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10272182/
https://www.ncbi.nlm.nih.gov/pubmed/37322055
http://dx.doi.org/10.1038/s41598-023-35627-1
work_keys_str_mv AT choinayeon theuseofartificialintelligencemodelstopredictsurvivalinpatientswithlaryngealsquamouscellcarcinoma
AT kimjunghyun theuseofartificialintelligencemodelstopredictsurvivalinpatientswithlaryngealsquamouscellcarcinoma
AT yiheejun theuseofartificialintelligencemodelstopredictsurvivalinpatientswithlaryngealsquamouscellcarcinoma
AT kimheejung theuseofartificialintelligencemodelstopredictsurvivalinpatientswithlaryngealsquamouscellcarcinoma
AT kimtaehwan theuseofartificialintelligencemodelstopredictsurvivalinpatientswithlaryngealsquamouscellcarcinoma
AT chungmyungjin theuseofartificialintelligencemodelstopredictsurvivalinpatientswithlaryngealsquamouscellcarcinoma
AT jimigyeong theuseofartificialintelligencemodelstopredictsurvivalinpatientswithlaryngealsquamouscellcarcinoma
AT kimzero theuseofartificialintelligencemodelstopredictsurvivalinpatientswithlaryngealsquamouscellcarcinoma
AT sonyoungik theuseofartificialintelligencemodelstopredictsurvivalinpatientswithlaryngealsquamouscellcarcinoma
AT choinayeon useofartificialintelligencemodelstopredictsurvivalinpatientswithlaryngealsquamouscellcarcinoma
AT kimjunghyun useofartificialintelligencemodelstopredictsurvivalinpatientswithlaryngealsquamouscellcarcinoma
AT yiheejun useofartificialintelligencemodelstopredictsurvivalinpatientswithlaryngealsquamouscellcarcinoma
AT kimheejung useofartificialintelligencemodelstopredictsurvivalinpatientswithlaryngealsquamouscellcarcinoma
AT kimtaehwan useofartificialintelligencemodelstopredictsurvivalinpatientswithlaryngealsquamouscellcarcinoma
AT chungmyungjin useofartificialintelligencemodelstopredictsurvivalinpatientswithlaryngealsquamouscellcarcinoma
AT jimigyeong useofartificialintelligencemodelstopredictsurvivalinpatientswithlaryngealsquamouscellcarcinoma
AT kimzero useofartificialintelligencemodelstopredictsurvivalinpatientswithlaryngealsquamouscellcarcinoma
AT sonyoungik useofartificialintelligencemodelstopredictsurvivalinpatientswithlaryngealsquamouscellcarcinoma